Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Rattus norvegicus | Inositol monophosphatase 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.0586 | 0.0158 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0029 | 0.0434 | 0.17 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0996 | 0.4427 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.2142 | 1 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.1044 | 1 |
Loa Loa (eye worm) | glutaminase | 0.0269 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.1199 | 0.1097 |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.0045 | 0.1044 | 0.4662 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0257 | 0.0257 |
Brugia malayi | Inositol-1 | 0.0045 | 0.1044 | 0.0637 |
Brugia malayi | glutaminase DH11.1 | 0.0269 | 1 | 1 |
Schistosoma mansoni | glutaminase | 0.0269 | 1 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.5022 | 0.4796 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0048 | 0.1199 | 0.0799 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.1044 | 1 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.004 | 0.0857 | 0.5 |
Onchocerca volvulus | 0.0233 | 0.8567 | 1 | |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0048 | 0.1199 | 0.1097 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.0257 | 0.0145 |
Schistosoma mansoni | inositol monophosphatase | 0.0045 | 0.1044 | 0.1044 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0021 | 0.0085 | 0.0085 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.111 | 0.0706 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.5022 | 0.4964 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.035 | 0.1287 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0045 | 0.1044 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.132 | 0.1219 |
Loa Loa (eye worm) | inositol-1 | 0.0045 | 0.1044 | 0.094 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.005 | 0.1257 | 0.5699 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.005 | 0.1257 | 0.5699 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.035 | 0.035 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1227 | 0.1126 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.035 | 0.1287 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.2315 | 0.2315 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0045 | 0.1044 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0205 | 0.7437 | 0.7408 |
Schistosoma mansoni | zinc finger protein | 0.0024 | 0.0206 | 0.0206 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0586 | 0.0586 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.005 | 0.1257 | 0.1257 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.5022 | 0.4964 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0048 | 0.1199 | 0.0799 |
Mycobacterium ulcerans | glutaminase | 0.0269 | 1 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.005 | 0.1257 | 0.1257 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0996 | 0.4427 |
Brugia malayi | Pre-SET motif family protein | 0.0205 | 0.7437 | 0.7321 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.1044 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0586 | 0.0477 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.2142 | 1 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.004 | 0.0857 | 0.5 |
Schistosoma mansoni | inositol monophosphatase | 0.0045 | 0.1044 | 0.1044 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.288 | 0.2557 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.1113 | 0.101 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.1044 | 1 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.0045 | 0.1044 | 0.4662 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0029 | 0.0434 | 0.0434 |
Echinococcus granulosus | zinc finger protein | 0.0024 | 0.0206 | 0.0592 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.1257 | 0.1156 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0045 | 0.1044 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0029 | 0.0434 | 0.0434 |
Plasmodium vivax | SET domain protein, putative | 0.0029 | 0.0434 | 0.5 |
Trichomonas vaginalis | set domain proteins, putative | 0.0233 | 0.8567 | 0.84 |
Echinococcus multilocularis | zinc finger protein | 0.0024 | 0.0206 | 0.0592 |
Trichomonas vaginalis | glutaminase, putative | 0.0269 | 1 | 1 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0028 | 0.0391 | 0.1491 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0021 | 0.0085 | 0.0085 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.2674 | 0.2589 |
Brugia malayi | PHD-finger family protein | 0.003 | 0.0464 | 0.0031 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.7079 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 1.7783 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.